Kanawha Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,210
Closed -$498K 168
2016
Q4
$498K Hold
6,210
0.08% 115
2016
Q3
$495K Hold
6,210
0.08% 115
2016
Q2
$484K Hold
6,210
0.08% 116
2016
Q1
$342K Hold
6,210
0.06% 135
2015
Q4
$384K Hold
6,210
0.07% 124
2015
Q3
$392K Hold
6,210
0.08% 119
2015
Q2
$454K Buy
6,210
+2,210
+55% +$160K 0.08% 120
2015
Q1
$262K Hold
4,000
0.05% 143
2014
Q4
$260K Hold
4,000
0.05% 138
2014
Q3
$241K Hold
4,000
0.04% 141
2014
Q2
$277K Hold
4,000
0.05% 137
2014
Q1
$262K Hold
4,000
0.05% 137
2013
Q4
$248K Hold
4,000
0.05% 135
2013
Q3
$215K Buy
+4,000
New +$206K 0.04% 138

Other funds holding STJ

Kanawha Capital Management's STJ Position: Q1 2017 in Review

Kanawha Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,210 shares — an estimated $498K sold.

Kanawha Capital Management first reported a position in STJ in Q3 2013 and held it in 14 quarters. The position peaked at $498K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Kanawha Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Kanawha Capital Management sold 6,210 St Jude Medical shares in Q1 2017, an estimated $498K.
  • Kanawha Capital Management first reported a position in St Jude Medical in Q3 2013 and held it in 14 quarters.
  • Kanawha Capital Management's St Jude Medical position peaked at $498K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Kanawha Capital Management's 13F filing for Q1 2017, filed 26 Apr 2017.